HomeENSC • NASDAQ
add
Ensysce Biosciences Inc
Previous close
$2.07
Day range
$2.03 - $2.12
Year range
$1.62 - $14.67
Market cap
6.09M USD
Avg Volume
627.25K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 1.37M | 654.38% |
Operating expense | 1.20M | 0.72% |
Net income | -1.73M | 11.91% |
Net profit margin | -126.39 | 88.32% |
Earnings per share | -0.79 | 76.06% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.21M | 111.99% |
Total assets | 5.57M | 99.40% |
Total liabilities | 2.51M | 91.00% |
Total equity | 3.06M | — |
Shares outstanding | 2.97M | — |
Price to book | 1.46 | — |
Return on assets | -85.92% | — |
Return on capital | -135.43% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -1.73M | 11.91% |
Cash from operations | -2.71M | -17.19% |
Cash from investing | — | — |
Cash from financing | 1.87M | 3,742.52% |
Net change in cash | -840.92K | 64.38% |
Free cash flow | -2.02M | -9.26% |
About
Founded
2003
Headquarters
Website
Employees
8